These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32330994)

  • 21. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
    Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
    J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of abdominal ultrasonography in the analysis of endoscopic activity in patients with Crohn's disease: changes following treatment with immunomodulators and/or anti-TNF antibodies.
    Moreno N; Ripollés T; Paredes JM; Ortiz I; Martínez MJ; López A; Delgado F; Moreno-Osset E
    J Crohns Colitis; 2014 Sep; 8(9):1079-87. PubMed ID: 24613399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
    Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
    BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
    Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal wall thickness detected by multidetector spiral computed tomography enterography predicts the disease severity of Crohn's disease.
    Yang X; Yu L; Yu W; Tang M; He C; Li Z; Liu Z
    Scand J Gastroenterol; 2014 Jul; 49(7):807-13. PubMed ID: 24730384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive Ultrasonographic Score for Assessment of the Severity of Inflammatory Bowel Disease.
    Marin AM; Calapod OP; Moldoveanu AC; Tribus LC; Fierbințeanu-Braticevici C
    Ultrasound Med Biol; 2021 Apr; 47(4):932-940. PubMed ID: 33388210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasonographic scores for ileal Crohn's disease assessment: Better, worse or the same as contrast-enhanced ultrasound?
    Freitas M; de Castro FD; Macedo Silva V; Arieira C; Cúrdia Gonçalves T; Leite S; Moreira MJ; Cotter J
    BMC Gastroenterol; 2022 May; 22(1):252. PubMed ID: 35585503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between a clinical activity index (Harvey-Bradshaw-Index), laboratory inflammation markers and quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound in Crohn's disease.
    Girlich C; Schacherer D; Jung EM; Schreyer A; Büttner R
    Eur J Radiol; 2012 Jun; 81(6):1105-9. PubMed ID: 21439749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the intestinal ultrasound in Crohn's disease diagnosis and monitoring.
    Stenczel ND; Purcarea MR; Tribus LC; Oniga GH
    J Med Life; 2021; 14(3):310-315. PubMed ID: 34377195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimising monitoring in the management of Crohn's disease: a physician's perspective.
    Papay P; Ignjatovic A; Karmiris K; Amarante H; Milheller P; Feagan B; D'Haens G; Marteau P; Reinisch W; Sturm A; Steinwurz F; Egan L; Panés J; Louis E; Colombel JF; Panaccione R
    J Crohns Colitis; 2013 Sep; 7(8):653-69. PubMed ID: 23562672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Level of Fecal Calprotectin Correlates With Severity of Small Bowel Crohn's Disease, Measured by Balloon-assisted Enteroscopy and Computed Tomography Enterography.
    Arai T; Takeuchi K; Miyamura M; Ishikawa R; Yamada A; Katsumata M; Igarashi Y; Suzuki Y
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):56-62. PubMed ID: 27565523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
    Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
    J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colon Capsule Endoscopy in the Assessment of Mucosal Healing in Crohn's Disease.
    Papalia I; Tjandra D; Quah S; Tan C; Gorelik A; Sivanesan S; Macrae F
    Inflamm Bowel Dis; 2021 Nov; 27(Supplement_2):S25-S32. PubMed ID: 34791289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of gastrointestinal ultrasound with capsule endoscopy in patients with small bowel Crohn's disease.
    Welera Haissou E; Han ZM; Lu YS; Yan LH; Xu PC; Zhao XM; Zhi FC
    J Dig Dis; 2023 Apr; 24(4):278-283. PubMed ID: 37327014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Value of Quantitative Contrast-Enhanced Ultrasound in Comparison to Endoscopy in Children With Crohn's Disease.
    Ponorac S; Dahmane Gošnak R; Urlep D; Ključevšek D
    J Ultrasound Med; 2023 Jan; 42(1):193-200. PubMed ID: 35748308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comment on "Ultrasonographic scores for ileal Crohn's disease assessment: better, worse or the same as contrast‑enhanced ultrasound?".
    Nylund K; Novak K; Wilkens R
    BMC Gastroenterol; 2023 Aug; 23(1):265. PubMed ID: 37542237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.